Columbia University Health Sciences

New York, NY

Compare ↔

$11,171,826,995

Total funding

6,964

Grants

Funding over time

peak $729.4M · FY2005–25

$1B$750M$500M$250M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$9,765,327,537 · 6787

CDC$1,333,912,329 · 89

AHRQ$58,889,012 · 70

FDA$20,421,524 · 16

ATSDR$2,447,273 · 2

HHS (Other)$37,786 · 3

By mechanism

R01$5,076,621,325 · 2269

U01$679,524,595 · 167

U2G$674,444,514 · 36

U62$575,965,064 · 2

P01$407,466,497 · 369

T32$339,053,337 · 87

Investigators at Columbia University Health Sciences

Investigator-initiated All funding

Investigatorsi

Rising Stars

First grant in the last 5 yrs

1Jinsy Andrews$21,294,6492 gr 2Eric Anderson$11,474,9751 gr 3Robbie M Parks$4,132,1193 gr 4Osama Al Dalahmah$3,558,0853 gr 5Isabelle Veerle Suzanne Schrauwen$3,524,3884 gr 6Junhao Wen$3,462,6151 gr 7Gao Wang$3,372,1343 gr 8Talea Cornelius$3,273,4811 gr

Emerging Leaders

6–10 yrs in

1Magdalena Elzbieta Sobieszczyk$20,645,7532 gr 2Vilas Menon$12,301,0159 gr 3Keith M Diaz$12,226,3486 gr 4Jose Gutierrez$11,196,3584 gr 5Elizabeth Marjorie Cespedes Feliciano$11,082,6677 gr 6Louise E Bier$10,646,1191 gr 7Natura Myeku$10,531,6785 gr 8Daniel Sing-Kwong Tsze$10,304,0942 gr

All-Time

Most funded here, all years

1Wafaa M. El-Sadr$1,113,559,11921 gr 2Andrea B Troxel$185,878,73910 gr 3Stuart D Katz$171,255,56213 gr 4Jessica E. Justman$151,287,2277 gr 5Muredach P Reilly$136,077,01827 gr 6David Hoos$134,762,0468 gr 7Scott M Hammer$126,273,1576 gr 8Henry N Ginsberg$119,772,60351 gr

Largest grants

RAPID EXP. OF ART FOR HIV-INFECTED PERSONS IN SELECTED COUNTRIES FOR PEPFAR$128,882,815

U62 · FY2010 · PS

RAPID EXP. OF ART FOR HIV-INFECTED PERSONS IN SELECTED COUNTRIES FOR PEPFAR$127,703,044

U62 · FY2008 · PS

RAPID EXP. OF ART FOR HIV-INFECTED PERSONS IN SELECTED COUNTRIES FOR PEPFAR$113,247,929

U62 · FY2009 · PS

RAPID EXP. OF ART FOR HIV-INFECTED PERSONS IN SELECTED COUNTRIES FOR PEPFAR$74,804,595

U62 · FY2007 · PS

U2G · FY2015 · GH

RAPID EXP. OF ART FOR HIV-INFECTED PERSONS IN SELECTED COUNTRIES FOR PEPFAR$55,907,103

U62 · FY2011 · PS

RAPID EXP. OF ART FOR HIV-INFECTED PERSONS IN SELECTED COUNTRIES FOR PEPFAR$47,444,494

U62 · FY2006 · PS

U2G · FY2014 · GH

PS09-962 SUPPORTING THE IMPLEMEN & EXPANSION OF HIGH QUAL HIV PREVENTION, CARE$24,221,093

U2G · FY2016 · PS

GH13-1368, HQ, Global Technical Assistance$21,467,092

U2G · FY2016 · GH

GH11-11108: TECHNICAL ASSISTANCE TO THE MOH FOR HIV SVC (PEPFAR) - Mozambique$19,519,535

U2G · FY2016 · GH

Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$16,957,778

U19 · FY2022 · AG

Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$16,850,168

U19 · FY2023 · AG

Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$16,500,642

U19 · FY2024 · AG

PS09-962, Kenya: SUPPORTING THE IMPLEMEN & EXPANSION OF HIGH QUAL HIV PREVENTION, CARE$15,933,756

U2G · FY2015 · PS

Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$15,462,979

U19 · FY2025 · AG

PS10-10155, Mozambique: BUILDING MOZAMBICAN CAPACITY TO IMPLEMENT QUALITY HIV/AIDS PREV$13,307,972